MobiHealth News December 7, 2022
The Patent Trial and Appeal Board determined three AliveCor patents regarding the detection of heart conditions like cardiac arrhythmias were unpatentable.
Editor’s note: This article has been updated with additional comment from AliveCor.
Apple notched a win against AliveCor, a medical device company that makes personal ECGs, in a long-running battle over wearable heart-monitoring technology.
The U.S. Patent and Trademark Office’s Patent Trial and Appeal Board determined on Tuesday that three AliveCor patents regarding the detection of heart conditions like cardiac arrhythmias were not patentable. The board found the patents were “obvious” following earlier research and technology advancements.
In late 2020, AliveCor had sued the tech giant, alleging that tools included in the Apple Watch Series 4 and later...
Today's Sponsors
Today's Sponsor